Fair question.
Full text of article is available:
https://www.researchgate.net/figure/Models-of-payment-for-the-participation-of-research-subjects_tbl1_7737793
I searched my journal databases and there are just as many articles stating there are numerous disadvantages associated with payment of subjects. Payment is not common practice in Australia; more common in the US. Regardless, payment in Imagion's trial would require a fairly significant trial re-design...
Should we petition Red Cross to enable payment for plasma donations, and the sprog clinics to pay sperm donors also?
- Forums
- ASX - By Stock
- IBX
- Financial incentives for recruiting is not uncommon
Financial incentives for recruiting is not uncommon
-
-
-
Share
I think it's going to be really hard to get a 15 patient cohort without a trial redesign.
And then what about the next step, 300 people? You can understand the markets apprehension.
- There are more pages in this discussion • 13 more messages in this thread...
Featured News
Add IBX (ASX) to my watchlist
|
|||||
Last
8.7¢ |
Change
0.008(10.1%) |
Mkt cap ! $2.84M |
Open | High | Low | Value | Volume |
8.0¢ | 9.2¢ | 8.0¢ | $13.69K | 156.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8569 | 8.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.5¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8569 | 0.087 |
1 | 6707 | 0.082 |
1 | 12500 | 0.077 |
1 | 13155 | 0.076 |
3 | 70000 | 0.075 |
Price($) | Vol. | No. |
---|---|---|
0.095 | 10000 | 1 |
0.098 | 38041 | 1 |
0.099 | 44444 | 1 |
0.100 | 1250 | 1 |
0.120 | 22751 | 1 |
Last trade - 16.10pm 18/06/2024 (20 minute delay) ? |
Featured News
IBX (ASX) Chart |
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
SPONSORED BY The Market Online